OFF-BRAND GLEEVEC: A BUDGET-FRIENDLY ALTERNATIVE?

The introduction of off-brand imatinib represents a substantial opportunity for patients battling a certain type of cancer and other conditions. Original brand-name imatinib, commonly known as Gleevec, carries a steep price label, frequently causing accessibility for some individuals. Common vers